|
|
Influence of β-elemene on the secretion of angiotensin II and expression of AT1R in hepatic stellate cells |
Ling YANG1, Rui ZHU2, Qingjing ZHU3, Dan DAN1, Jin YE1(), Keshu XU1, Xiaohua HOU1 |
1. Department of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China; 2. Department of Traditional Chinese Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan 430022, China; 3. Department of Integrated Traditional Chinese Medicine and Western Medicine, Wuhan Municipal Hospital of Infectious Diseases, Wuhan 430022, China |
|
|
Abstract This study aims to investigate the influence of β-elemene on the secretion of angiotensin II (ANG II) and the expression of angiotensin receptor type 1 (AT1R) in hepatic stellate cells (HSCs). In vitro, HSC-T6 were cultured for 24 hours and then treated with different doses of β-elemene (2.5, 5 and 10 mg/L). A control group was also set up. The secretion of ANG II in the supernatant was detected by radioimmunoassay. The mRNA expression of AT1R at 4, 12 and 24 h after treatment was detected by reverse transcription-polymerase chain reaction (RT-PCR), respectively. The protein expression of AT1R was detected by western blot. At the 4th h, the ANG II secretion in the supernatant was significantly inhibited by 10 mg/L β-elemene compared with the control group (P<0.05), while 5.0 mg/L and 2.5 mg/L β-elemene had no inhibitory effect on the secretion of ANG II (P>0.05). At the time point of the 12th h, the secretion of ANG II in the supernatant treated with 10 mg/L and 5.0 mg/L β-elemene was significantly lower than the control (P<0.01, P<0.05). Following the treatment with 5.0 mg/L and 2.5 mg/L β-elemene for 24 h, significant inhibition of ANG II secretion was observed (P<0.05), but 10 mg/L β-elemene had no such effect. β-elemene significantly reduced the amount of AT1R mRNA in HSCs after the treatment for 4, 12, and 24 h in a dose-dependent manner. The expression of AT1R protein also decreased after the treatment with β-elemene for 24 h. β-elemene can inhibit the secretion of ANG II and the gene and protein expression of AT1R, which may be the mechanism by which β-elemene prevents the progress of hepatic fibrosis.
|
Keywords
liver cirrhosis
beta-elemene
hepatic stellate cells
angiotensin II
receptor, angiotensin, type 1
|
Corresponding Author(s):
YE Jin,Email:yejin8689@sina.com
|
Issue Date: 05 March 2009
|
|
1 |
Friedman S L. Mechanisms of hepatic fibrogenesis. Gastroenterology , 2008, 134(6): 1655-1669 doi: 10.1053/j.gastro.2008.03.003
|
2 |
Li X, Meng Y, Huang M L, Zhang X L, Zhang Z S. Angiotensin II stimulates platelet-derived growth factor-B expression in hepatic stellate cells by activating EGR-1. Nanfang Yike Daxue Xuebao , 2008, 28(6): 963-967 (in Chinese)
|
3 |
Liu J, Gong H, Zhang Z T, Wang Y. Effect of angiotensin II and angiotensin II type 1 receptor antagonist on the proliferation, contraction and collagen synthesis in rat hepatic stellate cells. Chin Med J (Engl) , 2008, 121(2): 161-165
|
4 |
Liu C, Guo G, Hu Z Y. Effect of zedoary rhizome on the renal interstitial fibrosis in rats induced unilateral ureteral obstruction. Shanghai Zhongyiyao Zazhi , 2006, 40(12): 71-73 (in Chinese)
|
5 |
Xi Z T, Dan C M, Jiang W L, Luan X Y, Li K K. The study on common burreed tuber and zedoary rhizome resisting hepatic fibrosis induced autoimmunity in rats. Zhongguo Zhongyao Zazhi , 2002, 27(12): 929-932 (in Chinese)
|
6 |
Yang L, Qian W, Hou X H. Effect of the extract from Zedoray rhizome on ANG II and AT1R of rat liver fibrosis. Zhonghua Ganzangbing Zazhi , 2006, 14(4): 303-305 (in Chinese)
|
7 |
Yang L, Qian W, Hou X H. Effect of β-elemene on the cycle and apoptosis of hepatic stellate cells. Zhonghua Xiaohua Zazhi , 2006, 28(8): 555-556 (in Chinese)
|
8 |
Bataller R, Ginès P, Nicolás J M, G?rbig M N, Garcia-Ramallo E, Gasull X, Bosch J, Arroyo V, Rodés J. Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology , 2000, 118(6): 1149-1156 doi: 10.1016/S0016-5085(00)70368-4
|
9 |
Bataller R, Brenner D A. Liver fibrosis. J Clin Invest , 2005, 115(2): 209-218
|
10 |
Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev , 2006, 86(3): 747-803 doi: 10.1152/physrev.00036.2005
|
11 |
Bader M, Ganten D. Update on tissue rennin-angiotensin systems. J Mol Med , 2008, 86(6): 615-621 doi: 10.1007/s00109-008-0336-0
|
12 |
Yoshiji H, Noguchi R, Ikenaka Y, Kitade M, Kaji K, Tsujimoto T, Uemura M, Fukui H. Renin-angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Curr Med Chem , 2007, 14(26): 2749-2754 doi: 10.2174/092986707782360169
|
13 |
Kobori H, Nangaku M, Navar L G, Nishiyama A. The intrarenal rennin-Angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev , 2007, 59(3): 251-287 doi: 10.1124/pr.59.3.3
|
14 |
Wei H, Lu H, Li D, Zhan Y, Wang Z, Huang X. Effects of AT1 receptor antagonist, losartan, on rat hepatic fibrosis induced by CCl4. World J Gastroenterol , 2000, 6(4): 540-545
|
15 |
Jonsson J R, Clouston A D, Ando Y, Kelemen L I, Horn M J, Adamson M D, Purdie D M, Powell E E. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology , 2001, 121(1): 148-155 doi: 10.1053/gast.2001.25480
|
16 |
Yoshiji H, Kuriyama S, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology , 2001, 34(4 Pt 1): 745-750
|
17 |
González-Abraldes J, Albillos A, Ba?ares R, Del Arbol L R, Moitinho E, Rodríguez C, González M, Escorsell A, García-Pagán J C, Bosch J. Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology , 2001, 121(2): 382-388 doi: 10.1053/gast.2001.26288
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|